Drug Pipeline News

>

Latest News

FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa | Image credit: Contemporary Pediatrics
FDA expands B-VEC label to include patients from birth with dystrophic epidermolysis bullosa

September 15th 2025

The updated label is based on real-world data collected since B-VEC was launched in the United States, following its approval in May of 2023.

LOTUS study: Trofinetide data show Rett syndrome symptom improvement | Image Credit: © ARBA - © ARBA - stock.adobe.com.
LOTUS study: Trofinetide data show Rett syndrome symptom improvement

September 15th 2025

Weekly review: Florida vaccine eliminations, AI scribes, and more
Weekly review: Florida vaccine eliminations, AI scribes, and more

September 8th 2025

FDA Approves First Recombinant VWF for Pediatric von Willebrand Disease
FDA approves first recombinant VWF for pediatric von Willebrand disease

September 6th 2025

 Arcutis submits sNDA for roflumilast cream 0.3% for treatment of psoriasis in children 2-5 years | Image credit: Contemporary Pediatrics
Arcutis submits sNDA for roflumilast cream 0.3% for treatment of psoriasis in children 2-5 years

September 3rd 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.